This article is a work in progress. If you have any questions, thoughts, or corrections, contact us.

Playbooks

Building an originator pipeline

Capital Provider

Building an originator pipeline

Finding originators is easy. Winning the ones worth having is hard. The best originators have options: banks, other credit funds, and insurance companies all want their flow. Your job is to identify high-quality originators, position your fund competitively, and build relationships that convert to exclusive or preferred partnerships.

This guide walks through the full pipeline: sourcing, qualifying, approaching, winning, and managing originator relationships over time.


Identifying quality originators

Where to find them

Start with the public record. State licensing databases reveal every licensed lender by asset class and geography. If you’re focused on consumer lending in California, you can pull every licensed lender from the DFPI in minutes.

ABS deal databases (Finsight, ABSNet, Bloomberg) show recent issuers and warehouse borrowers. An originator who closed a warehouse 18 months ago is likely approaching capacity and open to conversations about incremental facilities.

Fintech funding databases (Crunchbase, PitchBook) identify lending startups that raised equity and will need debt. A $50M Series B closed six months ago means they’re scaling originations and need capital to match.

Industry association member directories (ELFA for equipment, CFA for commercial finance, SFIG for structured products) provide curated lists of active market participants. Conference attendee lists are even better: these are people actively investing time in industry relationships.

LinkedIn search combines “Founder” or “CEO” with “lending” and your target asset class. This surfaces smaller originators without public profiles.

Quality signals to prioritize

Not all originators are worth pursuing. Prioritize based on these signals:

Management with track record. Look for teams with prior exits, successful lending operations, or senior experience at established platforms. A first-time founder with no credit background is a different risk profile than a 20-year veteran who ran consumer lending at a major bank.

Reputable equity backing. When Insight Partners or QED Investors backs an originator, they’ve done diligence you can leverage. The equity check signals institutional confidence.

Existing capital relationships they’ve outgrown. An originator with a $75M warehouse from a regional bank, growing originations at 30% annually, needs more capacity. They’re not starting from zero, but they have a clear reason to talk to you.

Differentiated origination channel. Proprietary customer acquisition (direct mail, digital, point-of-sale integrations) beats broker-dependent models. Broker-sourced originators compete on price and often see higher defaults.

Strong unit economics at current scale. Ask early about cost to acquire, loss rates, and all-in yields. If the math only works at 10x their current volume, the growth path is risky.

Red flags in the pipeline

Some originators aren’t worth the cycle time:

  • Shopping the entire market simultaneously. If they sent the same deck to 15 funds, you’re in a price auction. Walk away unless you have a structural edge.
  • Management with no credit experience. Lending is an operating business, not just a tech play. Inexperience shows up in underwriting and servicing failures.
  • Venture burn rates requiring heroic growth. A company burning $5M/month that needs to 4x volume to reach breakeven is a credit risk, not just an equity risk.
  • Regulatory issues. Active enforcement actions, consent orders, or state license suspensions are disqualifying. Check NMLS and state regulator websites.
  • High originator churn. When senior leaders and key underwriters keep leaving, something is wrong.
  • Declining origination volume. Quarter-over-quarter declines signal competitive or operational problems.

What makes a credit fund attractive to originators

The originator’s decision framework

Originators evaluate capital providers on five dimensions, roughly in this order:

  1. Cost of capital. All-in yield including spread, fees, and structural costs. Lower is better, obviously.
  2. Speed. How fast can you close the facility? How fast do you fund draws? Days matter.
  3. Certainty. Will you actually close? Will you re-trade terms at the last minute?
  4. Flexibility. Can you accommodate growth, new products, and reasonable exceptions?
  5. Partnership mindset. When problems arise (and they will), will you be constructive or adversarial?

Banks win on cost. You need to win on everything else.

Where credit funds can compete with banks

Speed. Banks take 6-12 months to close a warehouse. Internal approvals, credit committee backlogs, legal review cycles, and compliance sign-offs all add time. A well-organized credit fund can close in 6-12 weeks. For an originator constrained by capacity, three months of additional origination time is worth 50-100 basis points.

Flexibility. Banks have rigid eligibility criteria, concentration limits, and advance rate grids. If an originator has a new product, non-standard collateral, or a shorter track record, banks often can’t (or won’t) accommodate. Credit funds can.

Attention. At a large bank, an originator is one of 200 warehouse clients handled by a rotating cast of relationship managers. At a credit fund, they’re one of 10-20 partners with direct access to the portfolio manager and credit committee.

Structural creativity. You can customize advance rates, concentration limits, and eligibility criteria to fit the originator’s actual portfolio, not a one-size-fits-all template.

Growth alignment. Banks often commit to a fixed facility size and make increases difficult. Credit funds can underwrite to a growth trajectory and increase commitments as the originator scales.

Where credit funds typically lose

Be honest about your disadvantages:

Cost. Bank warehouse pricing runs SOFR + 150-250 bps. Fund pricing runs SOFR + 300-500 bps. That’s a real gap, especially at scale.

Leverage. Banks offer higher advance rates due to regulatory capital treatment. A bank might offer 85% advance rates where a fund offers 75%.

Balance sheet. Banks can commit $500M to a single originator. Most funds max out at $100-200M per relationship.

Ancillary services. Banks offer treasury, cash management, and a clear path to term ABS takeout. Funds typically just offer the facility.

Positioning against the competition

Lead with speed and certainty, not price. An originator who needs capital in 60 days will pay for speed. An originator who’s been burned by re-trades will pay for certainty.

Emphasize relationship and access. “You’ll have my cell phone and direct access to our credit committee” resonates with originators tired of navigating bank bureaucracies.

Offer flexibility that banks can’t (or won’t). New asset class? Thinner credit files? Concentrated geography? These are opportunities for funds.

Be honest about trade-offs. Originators respect candor. If you’re more expensive than their bank warehouse, acknowledge it and articulate why the premium is worth paying.


The approach

Pre-approach research

Before you reach out, understand their situation:

Current capital structure. Check public filings, press releases, and LinkedIn for clues. Who are their existing capital providers? How large are current facilities? When do they expire?

Origination volume and trajectory. Growing 50% annually? Flat? Declining? The growth trajectory determines their capital needs.

Pain points. Are they capacity-constrained? Paying too much? Dealing with slow counterparties? Frustrated by rigid eligibility criteria? The pain point determines your pitch.

Warm introduction path. Before going cold, look for shared connections: law firms, shared investors, industry contacts, former colleagues.

Cold outreach best practices

Keep it short. Three to four sentences max. Busy CEOs don’t read long emails.

Lead with specific knowledge of their business. “I saw you closed a $50M warehouse last year” beats “I represent a credit fund looking for opportunities.”

Articulate what you can offer, not what you want. Focus on their problem, not your mandate.

Propose a specific next step. “Worth a 15-minute call to see if there’s a fit?” beats “Let’s chat sometime.”

Example: “I saw you closed a $50M warehouse with [Bank] last year. We work with similar originators and can typically add $25-50M in incremental capacity at competitive terms, usually closing in 8-10 weeks. Worth a 15-minute call to see if there’s a fit?”

WARM introductions

Warm beats cold every time. Prioritize these introduction paths:

  • Law firms. Counsel who works with both parties can make introductions.
  • Shared investors. Equity investors in the originator, LPs in your fund.
  • Industry contacts. Connections from conferences or associations.
  • Prior colleagues. Former colleagues who’ve moved to the originator.
  • Service providers. Accountants, auditors, servicers with relationships to both parties.

The first meeting

Listen more than you talk. Your job in the first meeting is to understand their needs, not to pitch your fund.

Ask about their current capital stack. What’s working? What’s not working? What would they change if they could?

Understand their growth plans. Where do they want to be in 12 months? 24 months? What capital do they need to get there?

Be honest about fit. If your fund isn’t right for them, say so. You’ll build credibility for future conversations.

If there’s a fit, propose concrete next steps. “We’d need a loan tape sample and static pool data to put together indicative terms. I can turn around a preliminary term sheet in two weeks.”


Competitive positioning

Differentiating your fund

When you’re competing against other funds (or banks), differentiate on:

Speed to close. Document your track record. “We’ve closed eight facilities in the past year, average 56 days from term sheet to funding.” Specificity builds credibility.

Sector expertise. Deep knowledge of their specific asset class matters. If you’ve done 15 equipment finance deals, you understand TRAC leases and end-of-term risk in a way a generalist doesn’t.

Structural flexibility. Willingness to customize terms distinguishes you from rigid competitors.

Relationship quality. “You’ll work directly with me, not a junior analyst” appeals to originators tired of relationship manager churn.

Track record and references. Offer references proactively. “Here are three originator partners you can call.”

Handling price objections

“Your pricing is 100 basis points wider than [Bank].” You’ll hear this constantly. Here’s how to handle it:

Acknowledge the gap honestly. Don’t pretend you’re price-competitive when you’re not.

Quantify the value of speed, certainty, and flexibility. “If we close three months faster, you originate $30M more in volume. At a 3% net margin, that’s $900K in incremental profit. The pricing gap costs you $300K. You come out $600K ahead.”

Propose structures that reduce effective cost. Higher advance rates, lower commitment fees, volume-based pricing tiers, and reduced reserves all narrow the effective gap.

Know when to walk away. Some deals aren’t worth winning on price alone. If you’re cutting margin to win, you’re building a portfolio of your worst deals.

Winning competitive processes

When you’re in a formal process with multiple bidders:

  • Respond to RFPs promptly and completely. Missing the deadline or leaving sections blank signals lack of commitment.
  • Don’t over-promise on terms you can’t deliver. Re-trading later destroys trust.
  • Offer references proactively. Make it easy for them to check on you.
  • Be available. Quick email responses and flexible scheduling signal commitment.
  • Understand their timeline and decision process. Ask who’s making the decision and when.

Exclusivity vs. diversified flow

Three models for originator relationships:

Exclusivity. You get all their flow. In return, you commit larger capacity and better pricing. Higher commitment, deeper relationship, but concentrated risk.

Non-exclusive. You’re one of several capital providers. Lower commitment, but you may see adverse selection (they send their best collateral to the cheaper provider).

Preferred provider. Middle ground. Volume commitments with pricing tiers. “Send us $100M annually and pricing steps down 25 basis points.”

Match the model to the originator’s quality and your risk appetite.


From pipeline to partnership

Moving from initial meeting to term sheet

Summarize the conversation in writing within 24 hours. Confirm what you heard about their needs, capital structure, and timeline. This demonstrates attention and creates a reference point.

Identify next steps and own the follow-up. Don’t leave it at “let’s stay in touch.” Set a specific date for the next call or data exchange.

Request preliminary data. A loan tape sample and static pool data let you underwrite indicative terms. Ask for what you need to move forward.

Set realistic timeline expectations. If your credit committee meets monthly, say so. Don’t promise a term sheet in a week if your process takes three.

Provide a draft term sheet within 2-3 weeks if there’s genuine interest. Momentum matters. Letting weeks pass without a term sheet signals lack of conviction.

The term sheet process

Start with your standard term sheet. Customize based on their specific needs and portfolio characteristics, but don’t reinvent the wheel for every deal.

Be clear about what’s negotiable and what isn’t. Some terms are credit policy (not negotiable). Others are commercial (negotiable within reason). Transparency saves cycles.

Price to a range initially. “SOFR + 350-400 bps, depending on diligence findings” gives you room to adjust without re-trading.

Include a reasonable exclusivity period. 30-45 days for serious discussions. Exclusivity demonstrates commitment from both sides.

Set expiration dates. Don’t leave term sheets outstanding indefinitely. “This term sheet expires in 30 days” creates urgency and prevents stale commitments.

From term sheet to close

Once a term sheet is signed, the process follows a predictable path:

  1. Detailed diligence. Deep dive on the originator (operations, financials, management) and portfolio (loan tape analysis, re-underwriting sample loans).
  2. Legal documentation. Credit agreement, security agreement, servicing agreement. Budget 4-6 weeks for negotiation.
  3. Third-party reports. Servicer assessment, collateral review, legal opinions.
  4. Credit committee approval. Formal approval based on diligence findings.
  5. Closing and funding. Signing, perfection of security interests, initial draw.

Note: The fastest way to accelerate this process is to start legal documentation in parallel with diligence, not sequentially.

Building the long-term relationship

Closing the facility is the beginning, not the end.

Regular portfolio reviews. Monthly for larger facilities, quarterly for smaller ones. Review performance, discuss issues, understand their evolving needs.

Proactive communication. When issues arise (and they will), call early. Don’t wait for the monthly report.

Flexibility on reasonable requests. Eligibility criteria tweaks, temporary concentration limit exceptions, and holiday draws all build goodwill.

Support their growth. Increase commitments as they scale. Expand eligible assets as they launch new products.

Relationship continuity. Don’t churn relationship managers. Institutional knowledge matters.


Pipeline management and metrics

Tracking your pipeline

Maintain a CRM with all originator contacts and interaction history. Spreadsheets work early, but break down as your pipeline grows.

Track pipeline stages explicitly:

StageDefinition
IdentifiedOriginator on your target list, no outreach yet
ContactedInitial outreach sent
Meeting heldFirst conversation completed
Term sheetActive term sheet discussions
DiligenceSigned term sheet, conducting due diligence
ClosedFacility funded

Review the pipeline weekly with your team. Identify stalled opportunities and discuss how to move them forward or remove them.

Key metrics to monitor

Volume metrics:

  • Number of originators in pipeline by stage
  • New originators added per month
  • Closed facilities per quarter

Conversion metrics:

  • Conversion rate by stage (contacted to meeting, meeting to term sheet, term sheet to close)
  • Time in each stage
  • Win rate on competitive processes

Quality metrics:

  • Source of closed deals (conferences, direct outreach, referrals, agents)
  • Referrals from existing originator partners
  • Renewal rates and facility increases

Pipeline health indicators

A healthy pipeline shows:

  • Diversification across asset classes (if you’re multi-strategy)
  • Steady flow of new additions, not just recycling the same names
  • Improving conversion rates over time as you refine your approach
  • Referrals from existing partners, signaling relationship quality
  • Repeat business and increases with current relationships

If your pipeline is thin, focus upstream on sourcing and outreach. If your pipeline is full but conversion is low, examine your positioning and term sheet process.


Summary

Building an originator pipeline is a sales and relationship job. The best capital means nothing if you can’t get it deployed.

Identify quality originators through public records, deal databases, and industry networks. Qualify them rigorously: management track record, equity backing, growth trajectory, and unit economics all matter.

Position your fund on speed, certainty, flexibility, and relationship, not price. You’ll rarely win on cost against banks. Win on everything else.

Approach systematically: research before outreach, pursue warm introductions, and lead first meetings with listening rather than pitching.

Move from meeting to term sheet quickly. Momentum matters. Set clear timelines, request data promptly, and turn around term sheets within weeks, not months.

Manage your pipeline with discipline. Track stages, measure conversion, and review weekly. A healthy pipeline is diversified, constantly replenished, and converting at improving rates.

The originators worth winning have options. Your job is to be the option they choose.


Cross-references